Skip to main content
. 2023 Feb 27;15(5):1505. doi: 10.3390/cancers15051505

Figure 1.

Figure 1

Test rate (number of tests versus number of diagnosed non-squamous non-small cell lung cancer patients) and fraction of positive tests per year in the period 2013–2020. Left panel represents EGFR tests and right panel represents ALK tests.